Surveillance, Epidemiology, And End Results (SEER) 2018

IDIQ

Description

Provide population-based central cancer registries in order to collect and report data on cancer incidence, treatment, and survival in the general population. The Surveillance Epidemiology and End Results (SEER) Program is the National Cancer Institute's main resource for tracking changes in cancer incidence, morbidity, and mortality.

Overview

Ceiling

$500,000,000

Primary Sponsoring Agency

National Cancer Institute (NCI) [HHS - NIH]

Who Can Use

One Agency

Primary NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Primary PSC

AN12 - Health R&D Services; Health Care Services; Applied Research

Primary Set Aside

None

Extent Competed

Full And Open Competition

Related Opportunity

Surveillance, Epidemiology, and End Results (SEER) Program (N01PC65003-74)

Predecessor

Surveillance, Epidemiology, And End Results (SEER) 2013

Surveillance, Epidemiology, And End Results (SEER) 2018 awarded by National Cancer Institute (NCI) in May 2018 accepts orders through April 2028. The IDIQ has a reported ceiling of $500,000,000, and as of today, $357,325,418 has been obligated through the vehicle with a total reported backlog of $134,986,495 and funded backlog of $1,275,581 from all task orders. The IDIQ was awarded full & open and has a primary NAICS code of 541715.

Award Hierarchy

Vehicle

Surveillance, Epidemiology, And End Results (SEER) 2018

Indefinite Delivery Vehicles

Prime Contracts

Subcontracts

Status

Period of Performance

5/1/18

Start Date

4/30/28

Ordering Period End Date

77.0% Complete

Task Order Obligations and Backlog

$357.3M

Total Obligated

$358.6M

Current Award

$492.3M

Potential Award

73% Funded

$1.3M

Funded Backlog

$135.0M

Total Backlog

Vehicle Award Share

Contractors with greatest percentage of obligations for Surveillance, Epidemiology, And End Results (SEER) 2018

Vehicle Award Share

Federal Award Analysis